Crinetics Pharmaceuticals CRNX

Monthly Leaders · July 2026 · Updated September 4, 2026

Health CareNews Spike

Setup Snapshot

The Setup in One Card

How CRNX scored, how it moved against the market, and the catalyst behind the move. A high score means the stock deserves research time, not that it is a buy.

Friday Five Score

July 2026 Return

CRNX+123.20%

July 2026

+123.20% · Rank 1

Sector Trend

Improvingup 1.0 percent

Actionability

News Spike

Catalyst

Acquisition

Vertex agreed to acquire it for roughly $10 billion at $85 per share in cash

Top five stocks covered by The Friday Five in July, ranked by full month price return (June 30 close to July 31 close).

Continue the Research

Put CRNX Back in Context

The stock page is one piece of the weekly research. Continue with the original issue, the full public ranking, or the method behind the analysis.

Search Every Published Pick

Filter the full record by sector, issue or whether the pick beat the index.

Learn: Merger Arbitrage

Open the public plain-English explanation connected to this research.

← Back to the full scoreboard

This page is for educational and informational purposes only. It is not financial advice, investment advice, or a recommendation to buy or sell any security.